Literature DB >> 10373508

Highly divergent lentiviral Tat proteins activate viral gene expression by a common mechanism.

P D Bieniasz1, T A Grdina, H P Bogerd, B R Cullen.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) Tat protein (hTat) activates transcription initiated at the viral long terminal repeat (LTR) promoter by a unique mechanism requiring recruitment of the human cyclin T1 (hCycT1) cofactor to the viral TAR RNA target element. While activation of equine infectious anemia virus (EIAV) gene expression by the EIAV Tat (eTat) protein appears similar in that the target element is a promoter proximal RNA, eTat shows little sequence homology to hTat, does not activate the HIV-1 LTR, and is not active in human cells that effectively support hTat function. To address whether eTat and hTat utilize similar or distinct mechanisms of action, we have cloned the equine homolog of hCycT1 (eCycT1) and examined whether it is required to mediate eTat function. Here, we report that expression of eCycT1 in human cells fully rescues eTat function and that eCycT1 and eTat form a protein complex that specifically binds to the EIAV, but not the HIV-1, TAR element. While hCycT1 is also shown to interact with eTat, the lack of eTat function in human cells is explained by the failure of the resultant protein complex to bind to EIAV TAR. Critical sequences in eCycT1 required to support eTat function are located very close to the amino terminus, i.e., distal to the HIV-1 Tat-TAR interaction motif previously identified in the hCycT1 protein. Together, these data provide a molecular explanation for the species tropism displayed by eTat and demonstrate that highly divergent lentiviral Tat proteins activate transcription from their cognate LTR promoters by essentially identical mechanisms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10373508      PMCID: PMC84257          DOI: 10.1128/MCB.19.7.4592

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

1.  The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.

Authors:  L S Tiley; S J Madore; M H Malim; B R Cullen
Journal:  Genes Dev       Date:  1992-11       Impact factor: 11.361

2.  The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation.

Authors:  M B Feinberg; D Baltimore; A D Frankel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

3.  Mutational analysis of the equine infectious anemia virus Tat-responsive element.

Authors:  M Carvalho; D Derse
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

4.  Identification of lentivirus tat functional domains through generation of equine infectious anemia virus/human immunodeficiency virus type 1 tat gene chimeras.

Authors:  R Carroll; L Martarano; D Derse
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

5.  Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev protein.

Authors:  L S Tiley; M H Malim; H K Tewary; P G Stockley; B R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

6.  Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function.

Authors:  S J Madore; B R Cullen
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

7.  Mutational analysis of the conserved cysteine-rich region of the human immunodeficiency virus type 1 Tat protein.

Authors:  A P Rice; F Carlotti
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

8.  Human chromosome 12 is required for optimal interactions between Tat and TAR of human immunodeficiency virus type 1 in rodent cells.

Authors:  A Alonso; D Derse; B M Peterlin
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

9.  Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T.

Authors:  K Fujinaga; R Taube; J Wimmer; T P Cujec; B M Peterlin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

10.  Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous trans activators.

Authors:  R Carroll; B M Peterlin; D Derse
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

View more
  15 in total

Review 1.  P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II.

Authors:  D H Price
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  High-Efficiency Rescue of Equine Infectious Anemia Virus from a CMV-Driven Infectious Clone.

Authors:  Xue-Feng Wang; Bowen Bai; Yuezhi Lin; Ting Qi; Cheng Du; Mingxin Song; Xiaojun Wang
Journal:  Virol Sin       Date:  2019-08-02       Impact factor: 4.327

3.  Functional differences between human and bovine immunodeficiency virus Tat transcription factors.

Authors:  H P Bogerd; H L Wiegand; P D Bieniasz; B R Cullen
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Interactions between equine cyclin T1, Tat, and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1.

Authors:  R Taube; K Fujinaga; D Irwin; J Wimmer; M Geyer; B M Peterlin
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  The human endogenous retrovirus K Rev response element coincides with a predicted RNA folding region.

Authors:  J Yang; H Bogerd; S Y Le; B R Cullen
Journal:  RNA       Date:  2000-11       Impact factor: 4.942

6.  Cyclin T1 expression is mediated by a complex and constitutively active promoter and does not limit human immunodeficiency virus type 1 Tat function in unstimulated primary lymphocytes.

Authors:  Juan Martin-Serrano; Kelvin Li; Paul D Bieniasz
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

7.  High natural permissivity of primary rabbit cells for HIV-1, with a virion infectivity defect in macrophages as the final replication barrier.

Authors:  Hanna-Mari Tervo; Oliver T Keppler
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

8.  CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA.

Authors:  M E Garber; T P Mayall; E M Suess; J Meisenhelder; N E Thompson; K A Jones
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

9.  Replication of equine infectious anemia virus in engineered mouse NIH 3T3 cells.

Authors:  Baoshan Zhang; Ronald C Montelaro
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

10.  CDK9 inhibitor FIT-039 prevents replication of multiple DNA viruses.

Authors:  Makoto Yamamoto; Hiroshi Onogi; Isao Kii; Suguru Yoshida; Kei Iida; Hiroyuki Sakai; Minako Abe; Toshiaki Tsubota; Nobutoshi Ito; Takamitsu Hosoya; Masatoshi Hagiwara
Journal:  J Clin Invest       Date:  2014-07-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.